GlassScriptPhysician profile
Mina L Xu
NPI 1922286095
$8,892.42
in general payments reported to CMS, 2019-2025
5 companies · none reported in 2025
See the full distribution for Anatomic Pathology & Clinical Pathology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,517 · 2020: $6,294 · 2021: $90.50 · 2022: $27.57 · 2023: $500 · 2024: $463.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $500 · Travel and Lodging: $463.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $500.00 |
| Travel and Lodging | $463.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seagen INC. | $6,294.17 | 2020 | |
| Taiho Oncology, INC. | $1,517.00 | 2019 | |
| Celgene Corporation | $963.18 | 2023-2024 | |
| Blueprint Medicines Corporation | $90.50 | 2021 | |
| Foundation Medicine, INC. | $27.57 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mina Xu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.